FMC Corporation FMC Acquired in-process research and development expenses

Acquired in-process research and development expenses at other companies

iRhythm Holdings, Inc. IRTC

$296K0.0%

AnaptysBio, Inc.ANAB

$0—

BeldenBDC

$30.09M+5.9%

Oruka Therapeutics, Inc.ORKA

$29.15M+46.3%

ServiceTitan, Inc.TTAN

$684.75K—

Minerals TechnologiesMTX

$6.1M+5.2%

Other financials

Income statement

See full

Revenue$758.6M-4.1%

Gross profit$246.6M-22.1%

Operating income-$81.0M-239%

Net income-$281.3M-1,715%

EPS (diluted)-$2.25-1,775%

Balance sheet

See full

Cash & equivalents$390.9M+24.0%

Total debt$4.1B+0.2%

Total equity$1.8B-58.4%

Total assets$9.4B-20.2%

Cash flow

See full

Operating cash flow-$600.9M-10.3%

CapEx$16.6M-47.5%

Free cash flow-$617.5M-7.1%

Valuation

See full

Market cap$1.42B-59.1%

Enterprise value$5.09B-35.3%

P/S0.4×-0.4×

Profitability

See full

Gross margin35.3%-4.2pp

Operating margin-51.5%-63.4pp

Net margin-72.9%-80.9pp

FCF margin6.2%—

Returns & leverage

See full

Return on equity-80.7%-88.3pp

Debt / equity2.2×+1.3×

Current ratio1.3×-0.2×

Where this comes from

Reported directly by FMC Corporation in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff.

The official record: FMC Corporation’s 10-K, filed February 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about FMC Corporation's acquired in-process research and development expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is FMC Corporation's acquired in-process research and development expenses?: FMC Corporation (FMC) reported acquired in-process research and development expenses of $2.98M in Q4 2023.
What does acquired in-process research and development expenses mean?: Expenditures related to the acquisition of in-process research and development assets, typically through business combinations or asset purchases. This reflects the company's investment in external innovation to bolster its long-term product pipeline.